These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15110951)

  • 21. Screening for pulmonary arterial hypertension in systemic sclerosis.
    Vachiéry JL; Coghlan G
    Eur Respir Rev; 2009 Sep; 18(113):162-9. PubMed ID: 20956137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosis.
    Quinlivan A; Thakkar V; Stevens W; Morrisroe K; Prior D; Rabusa C; Youssef P; Gabbay E; Roddy J; Walker JG; Zochling J; Sahhar J; Nash P; Lester S; Rischmueller M; Proudman SM; Nikpour M
    Intern Med J; 2015 Nov; 45(11):1134-40. PubMed ID: 26337683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study.
    Thakkar V; Stevens W; Prior D; Youssef P; Liew D; Gabbay E; Roddy J; Walker JG; Zochling J; Sahhar J; Nash P; Lester S; Rischmueller M; Proudman SM; Nikpour M
    Arthritis Res Ther; 2013; 15(6):R193. PubMed ID: 24246100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment.
    Proudman SM; Stevens WM; Sahhar J; Celermajer D
    Intern Med J; 2007 Jul; 37(7):485-94. PubMed ID: 17547726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of DETECT Pulmonary Arterial Hypertension Algorithm According to the Hemodynamic Definition of Pulmonary Arterial Hypertension in the 2022 European Society of Cardiology and the European Respiratory Society Guidelines.
    Distler O; Bonderman D; Coghlan JG; Denton CP; Grünig E; Khanna D; McLaughlin VV; Müller-Ladner U; Pope JE; Vonk MC; Di Scala L; Lemarie JC; Perchenet L; Hachulla É
    Arthritis Rheumatol; 2024 May; 76(5):777-782. PubMed ID: 38146100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival.
    Humbert M; Yaici A; de Groote P; Montani D; Sitbon O; Launay D; Gressin V; Guillevin L; Clerson P; Simonneau G; Hachulla E
    Arthritis Rheum; 2011 Nov; 63(11):3522-30. PubMed ID: 21769843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary arterial hypertension in scleroderma: care gaps in screening.
    Pope JE
    Arthritis Res Ther; 2017 Jun; 19(1):128. PubMed ID: 28587630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Screening and diagnosis of pulmonary arterial hypertension. Comments regarding the latest guidelines from the European Societies of Cardiology and of Pulmonology].
    de Groote P; Lamblin N; Launay D; Bervar JF; Hachulla E
    Presse Med; 2010 Jun; 39 Suppl 1():1S16-21. PubMed ID: 20732613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pulmonary hypertension in connective tissue disease].
    Schwarz EI; Ulrich S
    Z Rheumatol; 2018 Apr; 77(3):219-230. PubMed ID: 29594374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme.
    Morrisroe K; Stevens W; Sahhar J; Rabusa C; Nikpour M; Proudman S;
    Arthritis Res Ther; 2017 Mar; 19(1):42. PubMed ID: 28270192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The methods for screening pulmonary hypertension related to systemic sclerosis in France. Descriptive survey of the French Research Group on Sclerosis].
    El Khattabi A; Tiev KP; Ziani M; Baret M; Genereau T; Cabane J;
    Presse Med; 2004 Oct; 33(17):1160-3. PubMed ID: 15523285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of pulmonary arterial hypertension in an Australian scleroderma population: screening allows for earlier diagnosis.
    Phung S; Strange G; Chung LP; Leong J; Dalton B; Roddy J; Deague J; Playford D; Musk M; Gabbay E
    Intern Med J; 2009 Oct; 39(10):682-91. PubMed ID: 19220532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary arterial hypertension: the most devastating vascular complication of systemic sclerosis.
    McLaughlin V; Humbert M; Coghlan G; Nash P; Steen V
    Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii25-31. PubMed ID: 19487219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for the early detection of pulmonary arterial hypertension in patients with systemic sclerosis: A systematic review and meta-analysis of long-term outcomes.
    Brown Z; Proudman S; Morrisroe K; Stevens W; Hansen D; Nikpour M
    Semin Arthritis Rheum; 2021 Jun; 51(3):495-512. PubMed ID: 33857705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.
    Williams MH; Handler CE; Akram R; Smith CJ; Das C; Smee J; Nair D; Denton CP; Black CM; Coghlan JG
    Eur Heart J; 2006 Jun; 27(12):1485-94. PubMed ID: 16682379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of exercise pulmonary arterial hypertension in scleroderma.
    Callejas-Rubio JL; Moreno-Escobar E; de la Fuente PM; Pérez LL; Fernández RR; Sánchez-Cano D; Mora JP; Ortego-Centeno N
    J Rheumatol; 2008 Sep; 35(9):1812-6. PubMed ID: 18634147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and risk factors for pulmonary arterial hypertension in a large group of β-thalassemia patients using right heart catheterization: a Webthal study.
    Derchi G; Galanello R; Bina P; Cappellini MD; Piga A; Lai ME; Quarta A; Casu G; Perrotta S; Pinto V; Musallam KM; Forni GL;
    Circulation; 2014 Jan; 129(3):338-45. PubMed ID: 24081970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Echocardiography as an outcome measure in scleroderma-related pulmonary arterial hypertension: a systematic literature analysis by the EPOSS group.
    Kowal-Bielecka O; Avouac J; Pittrow D; Huscher D; Behrens F; Denton CP; Foeldvari I; Humbert M; Matucci-Cerinic M; Nash P; Opitz CF; Rubin LJ; Seibold JR; Strand V; Furst DE; Distler O;
    J Rheumatol; 2010 Jan; 37(1):105-15. PubMed ID: 19955042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Definitions and diagnosis of pulmonary hypertension.
    Hoeper MM; Bogaard HJ; Condliffe R; Frantz R; Khanna D; Kurzyna M; Langleben D; Manes A; Satoh T; Torres F; Wilkins MR; Badesch DB
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D42-50. PubMed ID: 24355641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update in systemic sclerosis-associated pulmonary arterial hypertension.
    Gashouta MA; Humbert M; Hassoun PM
    Presse Med; 2014 Oct; 43(10 Pt 2):e293-304. PubMed ID: 25179278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.